HOME >> MEDICINE >> NEWS
Initial chemotherapy treatment reduces relapses in MS patients

DENVER, CO Mitoxantrone, a chemical routinely used to fight breast cancer, leukemia and malignant lymphoma, has found a new disease to battle: Multiple Sclerosis. Used in an initial intensive course of chemotherapy (induction therapy), mitoxantrone dramatically decreases disease activity in MS patients for at least four years, according to a study presented at the Annual Meeting of the American Academy of Neurology.

Induction therapy, frequently used against cancers, is designed to wipe out abnormal cells and allow for the regrowth of normal cells. Mitoxantrone for the treatment of MS has recently been approved by the U.S. Food and Drug Administration. It has been used to treat MS in France for more than a decade. Researchers from CHU Pontchaillou of Rennes, France, have demonstrated that mitoxantrone induction therapy for relapsing-remitting MS patients has produced dramatic results in disease activity.

Over the past ten years, 100 worsening relapsing-remitting MS patients were given initial mitoxantrone induction therapy for six months, with mitoxantrone combined with methylprednisolone administered intravenously on a monthly schedule. The annual relapse rate decreased significantly from 3.20 during the 12 months preceding mitoxantrone onset to 0.30 during the first year following induction onset, corresponding to a reduction of nearly 90 percent that was maintained for more than five years. The percentage of relapse-free patients was 76 percent at one year of follow-up, and was maintained at 64 percent, 45 percent, and 43 percent at years two, three and four, respectively, with a median time to the first relapse of 2.8 years.

The clinical benefit and reduction of disease activity supports our belief that mitoxantrone, as administered in this study, may be an effective induction treatment before initiating other long-term disease modifying therapies for worsening relapsing-remitting MS patients, commented study author Emmanuelle Le Pa
'"/>

Contact: Cheryl Alementi
calementi@aan.com
651-695-2737
American Academy of Neurology
17-Apr-2002


Page: 1 2

Related medicine news :

1. Initial findings of first comprehensive study into ageing process published
2. Initial Avon/NCI breast cancer research grants awarded in Progress for Patients awards program
3. Initially recommended drug dosages often too high, study finds
4. Initial clinical study shows safety and bioactivity of cancer vaccine
5. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
6. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
7. MRI better than current standard in assessing neoadjuvant chemotherapy for breast cancer
8. Older women can benefit from chemotherapy to treat breast cancer
9. Resistance to chemotherapy
10. New treatment rivals chemotherapy for lymphoma, U-M study finds
11. Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Initial chemotherapy treatment reduces relapses patients

(Date:11/26/2014)... (PRWEB) November 27, 2014 Recently, ... women’s special occasion dresses, has unveiled its 2014 Cyber ... on these new dresses, up to 90 percent off. ... to Dec. 3. Free delivery is provided for orders ... of women’s dresses, shoes, handbags and other fashion accessories. ...
(Date:11/26/2014)... Sweetdressy.com, the well-known wedding dress manufacturer for ... cheap prom dresses for ladies worldwide. Meanwhile, these graceful ... from Sweetdressy.com are very popular in the world and ... Sweetdressy.com now. , Sweetdressy.com believes that a company ... best items and best services. The spirit of the ...
(Date:11/26/2014)... a well-known wedding dress manufacturer and retailer, has recently ... . Included in the new range are hundreds of ... charming outfits are offered at deeply discounted prices, up ... all of the sweet 16 cocktail gowns are made ... all of them are set according to the latest ...
(Date:11/26/2014)... Norwalk Hospital is pleased to ... by the American Nurses Credentialing Center (ANCC). , ... of work environments where nurses can flourish. The ... Norwalk Hospital and identifies it as one of ... an organizations’ commitment to nurses and their contributions ...
(Date:11/26/2014)... WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- Deaf teens have ... detected at an early age, a new study suggests. ... who were diagnosed with permanent hearing loss through an infant ... the children at age 8 found that those who were ... better language and reading skills than deaf children who weren,t ...
Breaking Medicine News(10 mins):Health News:DressVe.com: Best 2014 Special Monday Sales Online 2Health News:Cheap Prom Dresses For Ladies Introduced At SweetDressy.com 2Health News:iFitDress.com: Trendy Sweet 16 Cocktail Dresses Unveiled 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 3Health News:Spotting Hearing Problems in Infancy May Boost Reading Skills in Deaf Teens 2
(Date:11/26/2014)... , Nov. 25, 2014  Medtronic,s ... has been widely discussed in the media ... also creating a stronger leading player in one ... Kalorama Information.  The healthcare market research firm said ... will feature a diverse set of solutions spanning ...
(Date:11/26/2014)... Heska Corporation (NASDAQ: HSKA ) - ( ... advanced veterinary diagnostic and other specialty veterinary products , announced ... The Benchmark Company, LLC,s Micro Cap Discovery Conference on Thursday, ... The Palmer House Hilton, 17 E. Monroe Street, ... Please email hska@haydenir.com or contact your Benchmark representative ...
(Date:11/26/2014)... 25, 2014  Array BioPharma Inc. (Nasdaq: ... its Chief Executive Officer, Ron Squarer ... conferences.  The public is welcome to participate ... Array BioPharma website:  www.arraybiopharma.com .Event: Piper Jaffray ...  Eastern Time Location: Palace Hotel, New York ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
Cached News: